LMWH = UFH for thrombocytopenia
25 results
1 - 25
LMWH = UFH for thrombocytopenia
Risk for heparin-induced thrombocytopenia (HIT) with either low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) - Thrombocytopenia
- Prevention of venous thromboembolism
Unfractionated heparin versus low molecular weight heparins for avoiding heparin‐induced thrombocytopenia in postoperative patients- LMWH better than unfractionated heparin for preventing DVT in medical patients
- Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes: Cochrane systematic review
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer
- Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy
- Low molecular weight heparins for acute coronary syndromes
- Anticoagulation for perioperative thromboprophylaxis in people with cancer
- Heparin versus placebo for non‐ST elevation acute coronary syndromes
- Heparin for the treatment of thrombosis in neonates
- Anticoagulation for people with cancer and central venous catheters
- Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery